Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sercan Aksoy

Showing results (121-130 of 206) with videos related to

Pageof 21
Sort By:
Turkish Journal of Medical Sciences|November 24, 2022
The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life studyDeniz Can Güven, Hasan Çağrı Yıldırım, Enes Erul, et al.
Journal of Clinical Medicine|April 26, 2025
Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center ExperienceOnur Baş, Mert Tokatlı, Naciye Güdük, et al.
Journal of Clinical Medicine|September 9, 2022
Blood Based Biomarkers as Predictive Factors for Hyperprogressive DiseaseHasan Cagri Yildirim, Deniz Can Guven, Oktay Halit Aktepe, et al.
Medicine|May 5, 2023
Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohortArif Akyildiz, Deniz Can Guven, Hasan Cagri Yildirim, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 18, 2015
Molecular subtypes in patients with inflammatory breast cancer; a single center experienceNeyran Kertmen, Taner Babacan, Ozge Keskin, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life dataOzturk Ates, O Berna Oksuzoglu, Burak Yasin Aktas, et al.
Medical Oncology (Northwood, London, England)|May 22, 2013
Arrhythmias during and after zoledronic acid infusion patients with bone metastasisOzan Yazici, Sercan Aksoy, Ozgul Ucar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2015
Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancerDogan Yazilitas, Mehmet Ali Nahit Sendur, Halit Karaca, et al.
Breast (Edinburgh, Scotland)|September 10, 2014
Impact of locoregional treatment on survival in patients presented with metastatic breast carcinomaMelis Gultekin, Ozan Yazici, Gulnihan Eren, et al.
Medical Oncology (Northwood, London, England)|August 8, 2014
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimenMehmet Ali Nahit Sendur, Nuriye Ozdemir, Tahsin Özatlı, et al.
Pageof 21

Showing results (121-130 of 206) with videos related to

Sort By:
Pageof 21
Turkish Journal of Medical Sciences|November 24, 2022
The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life studyDeniz Can Güven, Hasan Çağrı Yıldırım, Enes Erul, et al.
Journal of Clinical Medicine|April 26, 2025
Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center ExperienceOnur Baş, Mert Tokatlı, Naciye Güdük, et al.
Journal of Clinical Medicine|September 9, 2022
Blood Based Biomarkers as Predictive Factors for Hyperprogressive DiseaseHasan Cagri Yildirim, Deniz Can Guven, Oktay Halit Aktepe, et al.
Medicine|May 5, 2023
Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohortArif Akyildiz, Deniz Can Guven, Hasan Cagri Yildirim, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 18, 2015
Molecular subtypes in patients with inflammatory breast cancer; a single center experienceNeyran Kertmen, Taner Babacan, Ozge Keskin, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life dataOzturk Ates, O Berna Oksuzoglu, Burak Yasin Aktas, et al.
Medical Oncology (Northwood, London, England)|May 22, 2013
Arrhythmias during and after zoledronic acid infusion patients with bone metastasisOzan Yazici, Sercan Aksoy, Ozgul Ucar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2015
Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancerDogan Yazilitas, Mehmet Ali Nahit Sendur, Halit Karaca, et al.
Breast (Edinburgh, Scotland)|September 10, 2014
Impact of locoregional treatment on survival in patients presented with metastatic breast carcinomaMelis Gultekin, Ozan Yazici, Gulnihan Eren, et al.
Medical Oncology (Northwood, London, England)|August 8, 2014
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimenMehmet Ali Nahit Sendur, Nuriye Ozdemir, Tahsin Özatlı, et al.
Pageof 21